| CYTK Stock Yearly Return 2023 Table | ||||||||||||||||||||||||||||||
CYTK average annual return is presented with the assumption of reinvestments of any dividends on ex-date. |
| Average Annual Return Benchmarks |
|
Compare CYTK average annual return versus benchmarks: S&P Average Annual Return Dow Average Annual Return Nasdaq 100 Average Annual Return Russell 2000 Average Annual Return Gold Average Annual Return 10 Year Treasury Average Annual Return |
| CYTK Share Performance |
| CYTK Stock Yearly Return 2023 Chart | |||
Also see: • CYTK YTD return • CYTK average annual return 10 years | |||
| About Cytokinetics Inc |
| Cytokinetics is a biopharmaceutical company focused on discovering, developing and commercializing muscle activators and muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. Co.'s clinical-stage drug candidates are: Omecamtiv mecarbil, which is being evaluated for the potential treatment of heart failure; Reldesemtiv, which is being evaluated for treatment in patients with amyotrophic lateral sclerosis; Aficamten, which is an oral, small molecule cardiac myosin inhibitor being evaluated in patients with symptomatic, obstructive hypertrophic cardiomyopathy; and CK-3772271, its second cardiac myosin inhibitor. The CYTK stock yearly return is shown above.
The yearly return on the CYTK stock yearly return page and across the coverage universe of our site, is a measure of the annual return over the calendar year 2023 for the given stock. When performing this calculation it is important to factor in dividends, because a financial instrument's annual return is more than just the change in price if that instrument pays a dividend or coupon. One way to factor dividends into the return is simply to count them as cash — we don't do that here. Instead, our website aims to empower investors by performing the CYTK annual return calculation with any dividends reinvested as applicable (on ex-dates). |
| CYTK Current Stock Quote |
 Free CYTK Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: Don't Forget Dividends in Annual Return! | |
|
| Yearly Return Peers |
| Cytokinetics (CYTK) is categorized under the Healthcare sector; to help you further research average annual return performance across stocks, below are some other companies in the same sector:
DARE Average Annual Return |
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 9.5%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 9.5%.
Video: Don't Forget Dividends in Average Annual Return!